Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 42708-014

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 42708-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (42708 013 30)

Label (42708 013 30)
This appears to be a medication label for Atorvastatin Calcium, a medication used to lower cholesterol levels. The medication is available in 20mg tablets and the recommended dosage is not specified. The label indicates that the medication should be stored at room temperature and kept out of reach of children. The manufacturer and distributor of the medication is QPharma, Inc.*
FDA Label Image

Label (42708 014 30)

Label (42708 014 30)
This is a prescription drug called Atorvastatin Calcium. It comes in tablet form and the dosage should be determined by the package insert or a healthcare professional. It is to be stored at normal room temperature and should be kept tightly closed. This particular package contains 30 tablets with a lot number and expiration date printed on the packaging. It is distributed by QPharma Inc. and can only be obtained with a prescription. Not available.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
This appears to be a survival analysis table showing the cumulative hazard percentages of a certain medication (Atorvastatin) over a follow-up period of four years. The hazard ratio for the medication is also given as 0.53 with a confidence interval between 0.45 and 0.83. The meaning of "Placeho" is unclear.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
The text appears to illustrate a chart or a graph depicting two subjects who have experienced the condition of "E vert." The chart may represent the results of tests conducted on the effects of Horvastatin 10 mg and Sorvastatin 80 mg on individuals experiencing this condition. The chart may also show the time taken for individuals to reach the first major cardiovascular endpoint in years. Additionally, the text suggests that there is a statistical difference in the results, with a hazard ratio (HR) of 0.78 for Horvastatin 10 mg and 0.69 for Sorvastatin 80 mg, indicating that Horvastatin is 0.09 less hazardous than Sorvastatin. However, the chart itself is not provided, and the text seems incomplete to provide further context.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.